{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Amarin and FDA settle off-label suit",
"url": "https://www.lexblog.com/2016/03/09/2946-2/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-388XKY36",
"url": "https://www.lexblog.com/lib/388XKY36/"
},
"datePublished": "2016-03-09T16:47:51-05:00",
"dateModified": "2024-04-25T12:50:28-04:00",
"author": {
"@type": "Person",
"name": "Katharyn Grant (US), Robert Rouder (US), Saul Perloff (US)"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Norton Rose Fulbright"
},
"organizationScope": "at-publication",
"isPartOf": "The Brand Protection Blog",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://www.thebrandprotectionblog.com/?p=2946",
"sourceStability": "may-move"
}